{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:36Z","timestamp":1786119396744,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chengdu Medical Research Project","award":["2024439"],"award-info":[{"award-number":["2024439"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Alzheimer disease (AD) is a neurodegenerative disorder characterized by amyloid plaque deposition, neurofibrillary tangles, and chronic neuroinflammation. Due to its complexity and difficult-to-treat nature, it has cast a huge shadow over global health. In addition to genetic susceptibility, the development of AD is closely related to systemic inflammation. This study aims to evaluate the association between systemic inflammatory factors and AD through a bidirectional Mendelian randomization (MR) design. Our MR design incorporated aggregated data from extensive genome-wide association studies to investigate the causal relationship between genetically determined systemic inflammatory factors and AD. The MR analysis results identified 9 potential systemic inflammatory regulatory factors: C-X-C motif chemokine 5, interleukin-18 receptor 1, interleukin-6, and tumor necrosis factor, which were associated with an increased risk. Conversely, AD is significantly correlated with 5 circulating inflammatory regulatory factors, namely, tumor necrosis factor-related apoptosis-inducing ligand, stem cell factor, monocyte chemoattractant protein-4, interleukin-5, and cystatin D, which are considered downstream consequences of AD. It is worth noting that our results have, for the first time, clarified the significant roles of inflammatory factors such as cystatin D and monocyte chemoattractant protein-4 in AD, providing new markers and key targets for further exploration of the molecular mechanism and clinical diagnosis and treatment of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048136","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:04:18Z","timestamp":1777273458000},"page":"e48136","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causality relationship between 91 inflammatory factors and Alzheimer disease: A bidirectional Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2832-1959","authenticated-orcid":false,"given":"Qijia","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Sichuan Provincial Women\u2019s and Children\u2019s Hospital\/The Affiliated Women\u2019s and Children\u2019s Hospital of Chengdu Medical College, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyou","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Sichuan Provincial Women\u2019s and Children\u2019s Hospital\/The Affiliated Women\u2019s and Children\u2019s Hospital of Chengdu Medical College, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Sichuan Provincial Women\u2019s and Children\u2019s Hospital\/The Affiliated Women\u2019s and Children\u2019s Hospital of Chengdu Medical College, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Fourth People\u2019s Hospital of Chengdu\/The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4467-785X","authenticated-orcid":false,"given":"Tong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Fourth People\u2019s Hospital of Chengdu\/The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy.","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/pcn.13704","article-title":"Synergism of ApoE4 and systemic infectious burden is mediated by the APOE-NLRP3 axis in Alzheimer\u2019s disease.","volume":"78","author":"Liu","year":"2024","journal-title":"Psychiatry Clin Neurosci"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1742-2094-9-151","article-title":"Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice.","volume":"9","author":"Krstic","year":"2012","journal-title":"J Neuroinflammation"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","article-title":"Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease.","volume":"94","author":"Su","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ije\/dyaa241","article-title":"Systemic inflammatory regulators and risk of Alzheimer\u2019s disease: a bidirectional Mendelian-randomization study.","volume":"50","author":"Yeung","year":"2021","journal-title":"Int J Epidemiol"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/gutjnl-2022-327860","article-title":"Association between inflammatory bowel disease and Alzheimer\u2019s disease: multivariable and bidirectional Mendelian randomisation analyses.","volume":"72","author":"Jiang","year":"2023","journal-title":"Gut"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","article-title":"The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions.","volume":"90","author":"Andrews","year":"2023","journal-title":"EBioMedicine"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/14737159.2015.1002469","article-title":"Genetic diagnosis and prognosis of Alzheimer\u2019s disease: challenges and opportunities.","volume":"15","author":"Reitz","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications.","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jid.2023.10.016","article-title":"Mendelian randomization studies in atopic dermatitis: a systematic review.","volume":"144","author":"Elhage","year":"2024","journal-title":"J Invest Dermatol"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk.","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1212\/WNL.0000000000000013","article-title":"Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the guideline development subcommittee of the American Academy of Neurology.","volume":"82","author":"Minden","year":"2014","journal-title":"Neurology"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00198-023-06734-6","article-title":"Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.","volume":"34","author":"Tang","year":"2023","journal-title":"Osteoporosis Int"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"1370276","DOI":"10.3389\/fimmu.2024.1370276","article-title":"Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population.","volume":"15","author":"Long","year":"2024","journal-title":"Front Immunol"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12916-020-01778-5","article-title":"Mendelian randomization study of inflammatory bowel disease and bone mineral density.","volume":"18","author":"Wu","year":"2020","journal-title":"BMC Med"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ajhg.2023.06.005","article-title":"Multi-response Mendelian randomization: identification of shared and distinct exposures for multimorbidity and multiple related disease outcomes.","volume":"110","author":"Zuber","year":"2023","journal-title":"Am J Hum Genet"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"156843","DOI":"10.1016\/j.cyto.2024.156843","article-title":"Exploring the causal relationship between inflammatory cytokines and myasthenia gravis: a two-way Mendelian randomization study.","volume":"186","author":"Li","year":"2025","journal-title":"Cytokine"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease.","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-022-01118-0","article-title":"Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer\u2019s disease: results from the DELCODE study.","volume":"15","author":"Brosseron","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1567205013666160930110551","article-title":"Targeting tumor necrosis factor alpha for Alzheimer\u2019s disease.","volume":"14","author":"Decourt","year":"2017","journal-title":"Curr Alzheimer Res"},{"key":"R25-20260622","first-page":"358","article-title":"High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.","volume":"53","author":"Qi","year":"2018","journal-title":"Int J Oncol"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer.","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1523\/JNEUROSCI.2484-16.2017","article-title":"Peripheral tumor necrosis factor-alpha (TNF-\u03b1) modulates amyloid pathology by regulating blood-derived immune cells and glial response in the brain of AD\/TNF transgenic mice.","volume":"37","author":"Paouri","year":"2017","journal-title":"J Neurosci"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"pyae038","DOI":"10.1093\/ijnp\/pyae038","article-title":"Investigating the impact of IL-6 and CXCL8 on neurodegeneration and cognitive decline in Alzheimer disease.","volume":"28","author":"Jin","year":"2024","journal-title":"Int J Neuropsychopharmacol"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology.","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-024-03277-3","article-title":"Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer\u2019s disease mice.","volume":"21","author":"Liu","year":"2024","journal-title":"J Neuroinflammation"},{"key":"R31-20260622","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.1074\/jbc.M115.660175","article-title":"Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.","volume":"290","author":"Ferrer-Mayorga","year":"2015","journal-title":"J Biol Chem"},{"key":"R32-20260622","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.arr.2016.06.003","article-title":"Cystatin C in aging and in Alzheimer\u2019s disease.","volume":"32","author":"Mathews","year":"2016","journal-title":"Ageing Res Rev"},{"key":"R33-20260622","doi-asserted-by":"crossref","first-page":"1176639","DOI":"10.3389\/fimmu.2023.1176639","article-title":"CCL13 and human diseases.","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R34-20260622","doi-asserted-by":"crossref","first-page":"e30525","DOI":"10.1371\/journal.pone.0030525","article-title":"CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u2019s disease.","volume":"7","author":"Westin","year":"2012","journal-title":"PLoS One"},{"key":"R35-20260622","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-020-01968-1","article-title":"The immune system on the TRAIL of Alzheimer\u2019s disease.","volume":"17","author":"Burgaletto","year":"2020","journal-title":"J Neuroinflammation"},{"key":"R36-20260622","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.npp.1301185","article-title":"Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity.","volume":"32","author":"Uberti","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:28Z","timestamp":1786039708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":36,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048136","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2025-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}